Spaulding Clinical Research Announces Collaboration with Blinded Diagnostics for Centralized Cardiac Safety Services for Select Pharmaceutical Clients

Tools

Spaulding Clinical Research Announces Collaboration with Blinded Diagnostics for Centralized Cardiac Safety Services for Select Pharmaceutical Clients

December 3, 2012 – West Bend, Wisconsin, USA   Spaulding Clinical Research has agreed to offer ECG services using the new Spaulding webECGTM Diagnostic ECG Management system for late stage clinical trials through Blinded Diagnostics. This web-based solution includes the Spaulding Model  1000iQ, a hand-held diagnostic 12-lead electrocardiograph designed to provide an easy-to-use, cost-effective, diagnostic assessment, while centralizing all data on a web-based system that allows for immediate access to study data globally.  The multi-year collaboration assigns Blinded Diagnostics as a business development resource for a select group of pharmaceutical companies
"We are very pleased with the relationship that we have built with Blinded Diagnostics.  They are a knowledgeable and professional organization and will represent Spaulding's unique service offerings well.  We are confident in their ability to deliver customer-focused solutions to this select group of pharmaceutical companies," states Kevin Geno, VP of Sales and Marketing for Spaulding Clinical Research. 

"The Spaulding Model 1000iQ Electrocardiograph is an innovative and effective point of care 12-lead ECG device for use in clinical trials…" states Steve Karuppan, CEO of Blinded Diagnostics, "and we are particularly impressed by the Spaulding webECG data storage capability, analysis solutions and connectivity features for use in centralizing cardiac safety data from phase II-IV global trials."


About Spaulding Clinical Research, LLC
Spaulding Clinical Research, LLC (www.spauldingclinical.com) provides Clinical Pharmacology, Cardiac Core Lab clinical research services, and is a medical device manufacturer. Spaulding Clinical operates a 155-bed clinical pharmacology unit with 96-beds of telemetry in West Bend, Wisconsin, USA. The facility is paperless, with a Phase I Electronic Data Capture system and bi-directional interfaces to safety lab, bedside devices and telemetry. As a Phase I-IV Core ECG Laboratory provider, Spaulding Clinical offers the complete suite of equipment provisioning and electrocardiograph over-reading services with state-of-the-art technologies, including the proprietary Spaulding Model 1000iQ Electrocardiograph, expertly-cardiologists and project managers.

About Blinded Diagnostics LLC
Blinded Diagnostics, LLC (www.blindeddiagnostics.com) is a pioneering contract service organization, which specializes in sourcing and supporting point of care diagnostic test platforms in Clinical Research trials.  Blinded Diagnostics has a successful track record of expertise in meeting large pharmaceutical company testing needs with thorough knowledge of the protocol design, Investigator training and firmware encryption. As an innovator with partners in point-of-care diagnostics, Blinded Diagnostics is at the forefront of a paradigm shift that brings flexibility and efficiency for trial sponsors.

Spaulding Clinical Media Contact
Kathy Forde
Sr. Director of Marketing
Tel:  (414) 303-1912
Email:  kathy.forde@spauldingclinical.com